Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension (Q24338499)

Prostaglandin I2 receptor

inferred from title

1 reference

Peroxisome proliferator activated receptor gamma

1 reference

negative regulation of smooth muscle cell proliferation

1 reference

Prostaglandin I receptor (IP)

1 reference

idiopathic pulmonary arterial hypertension

0 references

Lucie H Clapp

7

1 reference

ORCID Public Data File 2021

author name string

Emilia Falcetti

1

0 references

Susan M Hall

2

0 references

Peter G Phillips

3

0 references

Jigisha Patel

4

0 references

Nicholas W Morrell

5

0 references

Sheila G Haworth

American Journal of Respiratory and Critical Care Medicine

6

0 references

language of work or name

English

0 references

publication date

1 November 2010

0 references

published in

0 references

volume

182

0 references

page(s)

1161-70

0 references

issue

9

0 references

cites work

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Role of prostacyclin in the cardiovascular response to thromboxane A2

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Prostanoid receptors: structures, properties, and functions

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

7 April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Therapeutic targets in pulmonary arterial hypertension

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Kinase signaling cascades that modulate peroxisome proliferator-activated receptors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Prostacyclin and its analogues in the treatment of pulmonary hypertension

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Multiple signalling options for prostacyclin.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Pulmonary hypertension in the young

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Primary pulmonary hypertension in children: clinical characterization and survival.

30 May 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Remodelling of the pulmonary arteries during recovery from pulmonary hypertension induced by neonatal hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0011OC

Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001258

Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors

29 November 2018

1 reference

12 December 2020

Synthetic Prostacyclin Analogs Differentially Regulate Macrophage Function via Distinct Analog-Receptor Binding Specificities

1 reference

12 December 2020

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension

1 reference

12 December 2020

Prostacyclin Analogues Differentially Inhibit Growth of Distal and Proximal Human Pulmonary Artery Smooth Muscle Cells

1 reference

12 December 2020